We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
46 result(s) found, displaying 21 to 30
-
Cancellation by sponsorRequested by Lundbeck Australia Pty Ltd
-
Cancellation by sponsorRequested by Lundbeck Australia Pty Ltd
-
Australian public assessment report (AusPar)Australian Public Assessment Report
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ABILIFY MAINTENA aripiprazole (as monohydrate) 300 mg powder and solvent for prolonged release suspension for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ABILIFY MAINTENA aripiprazole (as monohydrate) 400 mg powder and solvent for prolonged release suspension for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BRINTELLIX vortioxetine (as hydrobromide) 5 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BRINTELLIX vortioxetine (as hydrobromide) 15 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BRINTELLIX vortioxetine (as hydrobromide) 20 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BRINTELLIX vortioxetine (as hydrobromide) 10 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LEXAPRO escitalopram (as oxalate) 20 mg/mL oral solution bottle.